Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 10/2017

Cancer Immunology, Immunotherapy

Inhalt (13 Artikel)

Open Access Review

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer

Omid Hamid, Brianna Hoffner, Eduard Gasal, Jenny Hong, Richard D. Carvajal

Original Article

CD45RA−Foxp3high regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma

Fumie Ihara, Daiju Sakurai, Atsushi Horinaka, Yuji Makita, Akira Fujikawa, Toshioki Sakurai, Kazuki Yamasaki, Naoki Kunii, Shinichiro Motohashi, Toshinori Nakayama, Yoshitaka Okamoto

Open Access Original Article

Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro

Sarah J. Storr, Sabreena Safuan, Narmeen Ahmad, Mohammed El-Refaee, Andrew M. Jackson, Stewart G. Martin

Original Article

Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy

Simone Battella, M. Christina Cox, Raffaella La Scaleia, Arianna Di Napoli, Francesca Di Landro, Alessandra Porzia, Lavinia Franchitti, Fabrizio Mainiero, Luigi Ruco, Bruno Monarca, Angela Santoni, Gabriella Palmieri

Open Access Original Article

In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells

Yildian Díaz-Rodríguez, Paulo Cordeiro, Assila Belounis, Sabine Herblot, Michel Duval

Original Article

TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model

Fang Huang, Jiangbo Wan, Siguo Hao, Xiaohui Deng, Linjun Chen, Liyuan Ma

Open Access Original Article

Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists

Tanja Lövgren, Dhifaf Sarhan, Iva Truxová, Bhavesh Choudhary, Roeltje Maas, Jeroen Melief, Maria Nyström, Ulrika Edbäck, Renee Vermeij, Gina Scurti, Michael Nishimura, Giuseppe Masucci, Alex Karlsson-Parra, Andreas Lundqvist, Lars Adamson, Rolf Kiessling

Original Article

Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer

Guru Sonpavde, John D. McMannis, Yu Bai, Mamatha R. Seethammagari, Joan M. C. Bull, Victoria Hawkins, Theresa K. Dancsak, Natasha Lapteva, Jonathan M. Levitt, Annemarie Moseley, David M. Spencer, Kevin M. Slawin

Original Article

A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma

Sapna P. Patel, Dae Won Kim, Roland L. Bassett, Suzanne Cain, Edwina Washington, Wen-Jen Hwu, Kevin B. Kim, Nicholas E. Papadopoulos, Jade Homsi, Patrick Hwu, Agop Y. Bedikian

Original Article

Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions

Feng Xu, Alexander Sunderland, Yue Zhou, Richard D. Schulick, Barish H. Edil, Yuwen Zhu

Letter to the Editors

Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab

Markus V. Heppt, Ilana Goldscheider, Julia K. Tietze, Carola Berking

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.